Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
SRAM trial: what clinicians have said so far
SRAM study_Postate Cancer
- NCT03938649 ↗
- Active, not recruiting
- CCTU
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on SRAM (high-risk prostate cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on SRAM so far
Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 6 posts on X, typically up to 26 once built |
The trial
ClinicalTrials.gov- Official title
- Randomized Phase II Study of Combination Androgen Deprivation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer: Stereotactic Body Radiotherapy vs conventionAl IMRT to Prostate and Pelvic Nodes (SRAM Study)
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Advanced Prostate Cancer
- Interventions
- Conventional IMRT; SBRT
- Arms
- Conventional IMRT · Experimental
- SBRT · Experimental
- Enrollment
- 120 (estimated)
- Primary outcomes
- To compare acute toxicities between SBRT and conventional IMRT
- Sponsor
- CCTU
- Start
- May 15, 2019
- Primary completion
- Dec 31, 2027 (estimated)
- Results posted
- No
- Registry record
- NCT03938649 · updated Mar 4, 2026